Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

PDRN from trout sperm helps skin and hair regeneration but is costly and complex to produce.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

The skin microbiome is crucial for skin health, and more research is needed to explore its role and potential treatments.

Breast pain is common and usually not linked to cancer, with treatment varying by severity.

Acyzol could help treat conditions caused by zinc deficiency.

More research is needed to confirm if natural products effectively treat PCOS.

Acne may signal underlying metabolic issues, and lifestyle changes can help manage both.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

A mix of Polygonatum sibiricum and Nelumbinis semen may ease menopause symptoms with fewer side effects.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Oral contraceptives can affect skin and hair, improve acne, but may cause pigmentation, dermatitis, and other conditions.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

A 31-year-old woman was diagnosed with Complete Androgen Insensitivity Syndrome much later than usual, leading to a call for earlier detection and treatment guidelines.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

PCOS is linked to changes in vaginal bacteria, with fewer good bacteria and more harmful ones.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.